-transparent.png){kind=logo}
Iodine-131 labelled Biligram has been evaluated as a radiopharmaceutical for dynamic scintiscanning of the liver and biliary tract. In 10 normal subjects there was good visualisation of the liver and gallbladder. In 18 patients 131I Biligram was found to be unsatifactory for differentiating parenchymal liver disease from biliary tract obstruction owing to inability to demonstrate the gallbladder when liver function was more than mildly deranged. Quantitative analyses of blood clearance and hepatic activity curves for 131I Biligram were not clinically helpful. Urinary excretion of 131I Biligram increased with the degree of hepatic dysfunction.
Related Publications
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
January 1967,
Journal francais de medecine et chirurgie thoraciques,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
September 1959,
The Biochemical journal,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
January 1972,
Lyon medical,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
October 1957,
La Presse medicale,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
November 1965,
Nature,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
October 1959,
The British journal of radiology,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
August 1966,
Nature,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
February 1961,
Zeitschrift fur Urologie,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
March 1955,
Nature,
J N Blackwell, and
N D Finlayson, and
G P McLoughlin, and
M D Sumerling, and
P Tothill
June 1959,
Nature,
